Pinkeye Shield XT4 (Canada)This page contains information on Pinkeye Shield XT4 for veterinary use.
The information provided typically includes the following:
- Pinkeye Shield XT4 Indications
- Warnings and cautions for Pinkeye Shield XT4
- Direction and dosage information for Pinkeye Shield XT4
Pinkeye Shield XT4This treatment applies to the following species:
Moraxella Bovis Bacterin
For Use In Animals Only
Pinkeye Shield XT4 Indications
For use in healthy cattle as an aid in the prevention of pinkeye caused by Moraxella bovis.
ADJUVANT: Xtend® SP.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly in the neck. Revaccinate annually or as recommended by your veterinarian.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. Transient swelling may occur at the site of injection. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains thimerosal as a preservative.
U.S. Vet. License No. 303
Novartis Animal Health US, Inc.
©2012 Novartis; Registered trademarks of Novartis AG, used under license.
Novartis Animal Health Canada Inc., Mississauga, Ontario, Canada L5N 1V9
NAC No.: 1231043.4
Distributed by ELANCO, Division Eli Lilly Canada Inc. & ELANCO CANADA LIMITED (successor to Novartis Animal Health Canada Inc.)
RESEARCH PARK CENTRE, 150 RESEARCH LANE, SUITE 120, GUELPH, ON, N1G 4T2
|Elanco Canada Limited Customer Service Telephone:||800-387-6325|
|Elanco Canada Limited Customer Service Fax:||800-827-5782|
|Every effort has been made to ensure the accuracy of the Pinkeye Shield XT4 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2017 North American Compendiums. Updated: 2017-02-06